Telmisartan Tablets

Key Dates
Due Date

-

Posted Date

-

Agency & Value
Agency

DLA TROOP SUPPORT

Contract Value

Not provided

Codes & Classification
Solicitation Number

SPE2D2-26-D-0002

NAICS

325412 - Pharmaceutical Preparation Manufacturing

Classification Code

6505

Additional Details
Set Aside

None

Place of Performance

Brookhaven, New York, UNITED STATES

SourceSAM
Documents1
The Defense Logistics Agency (DLA) Troop Support has issued an award notice for a national contract pertaining to the supply of Telmisartan Tablets, a pharmaceutical product used primarily for the treatment of hypertension. This contract, identified by procurement number SPE2D2-26-D-0002, has been awarded to AvKARE, LLC, following the original solicitation under SPE2D2-24-R-0015. The scope of this procurement encompasses the manufacturing and delivery of Telmisartan Tablets, aligning with the NAICS code 325412, which covers Pharmaceutical Preparation Manufacturing as per the 2022 classification. The place of performance for this contract is Brookhaven, New York, indicating that the manufacturing, distribution, or other contract-related activities will be centered in this location. The product service code associated with this award is 6505, denoting Drugs and Biologicals, which further clarifies the nature of the deliverables expected under this agreement. DLA Troop Support, a federal office, serves as the contracting entity for this procurement. Contractors and stakeholders seeking further information or clarification regarding the contract may contact the designated representatives: Courtney Hunter ([email protected], 445-737-3585) and Catherine Gilbert ([email protected], 445-737-8868). These contacts are available to address inquiries related to contract administration, compliance, and ongoing requirements. The contract is currently active, as indicated by the notice status, and was posted on November 12, 2025. Interested parties can access additional details and the official award notice via the SAM.gov opportunity portal at https://sam.gov/opp/5334df7711b44579ae1dd7022ff6b624/view. One attachment is available for review, which may contain further specifications or terms relevant to the contract. This procurement represents a long-term commitment to ensuring the availability of Telmisartan Tablets for federal requirements, with AvKARE, LLC responsible for meeting the quality, regulatory, and delivery standards set forth by DLA Troop Support. The contract’s classification and scope suggest a focus on consistent supply, compliance with pharmaceutical manufacturing standards, and reliable distribution to meet the needs of the federal government. Contractors evaluating similar opportunities should note the emphasis on pharmaceutical expertise, regulatory compliance, and capacity for national-level fulfillment.